Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,415
Closed -$210K 494
2025
Q3
$210K Sell
7,415
-1,785
-19% -$47.4K ﹤0.01% 471
2025
Q2
$202K Hold
9,200
﹤0.01% 491
2025
Q1
$214K Buy
9,200
+1,860
+25% +$47.6K ﹤0.01% 455
2024
Q4
$211K Buy
7,340
+99
+1% +$2.96K ﹤0.01% 466
2024
Q3
$215K Buy
7,241
+280
+4% +$8.7K ﹤0.01% 457
2024
Q2
$235K Hold
6,961
﹤0.01% 429
2024
Q1
$251K Buy
6,961
+477
+7% +$16.5K 0.01% 423
2023
Q4
$212K Sell
6,484
-2,485
-28% -$76.8K 0.01% 447
2023
Q3
$292K Hold
8,969
0.01% 384
2023
Q2
$262K Buy
8,969
+1,628
+22% +$44.9K 0.01% 403
2023
Q1
$206K Buy
+7,341
New +$207K 0.01% 433

Other funds holding GNTX

Glenview Trust's GNTX Position: Q4 2025 in Review

Glenview Trust sold out of Gentex (GNTX) in Q4 2025, closing a stake of 7,415 shares — an estimated $210K sold.

Glenview Trust first reported a position in GNTX in Q1 2023 and held it in 11 quarters. The position peaked at $292K in Q3 2023. 524 funds tracked by Wall St. Rank hold GNTX as of Q4 2025.

  • Glenview Trust reported no remaining Gentex position as of Q4 2025 after selling out during the quarter.
  • Glenview Trust sold 7,415 Gentex shares in Q4 2025, an estimated $210K.
  • Glenview Trust first reported a position in Gentex in Q1 2023 and held it in 11 quarters.
  • Glenview Trust's Gentex position peaked at $292K in Q3 2023.
  • 524 funds tracked by Wall St. Rank held Gentex as of Q4 2025.

Based on Glenview Trust's 13F filing for Q4 2025, filed 9 Feb 2026.